Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8741911 Raf inhibitor compounds

Overview Structured Data Issues Contributors Activity

All edits

Edits on 2 Oct, 2024

"update inverses"

edited on 2 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12102620 Combination therapy for the treatment of mastocytosis

0

Edits on 28 Aug, 2024

"update inverses"

edited on 28 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12071432 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

0

Edits on 21 Aug, 2024

"update inverses"

edited on 21 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12064422 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

0

Edits on 14 Aug, 2024

"update inverses"

edited on 14 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12059411 Methods of treating gastrointestinal stromal tumors

0

"update inverses"

edited on 14 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12059410 Methods of treating gastrointestinal stromal tumors

0

Edits on 3 Jul, 2024

"update inverses"

edited on 3 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12023328 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

0

"update inverses"

edited on 3 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12023327 Methods of treating gastrointestinal stromal tumors

0

"update inverses"

edited on 3 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12023326 Methods of treating gastrointestinal stromal tumors

0

"update inverses"

edited on 3 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12023325 Methods of treating gastrointestinal stromal tumors

0

Edits on 22 May, 2024

"update inverses"

edited on 22 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11986463 Combination therapy for the treatment of gastrointestinal stromal tumor

0

Edits on 1 May, 2024

"update inverses"

edited on 1 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11969415 (methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

0

"update inverses"

edited on 1 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11969414 Methods of treating gastrointestinal stromal tumors

0

Edits on 12 Mar, 2024

"update inverses"

edited on 12 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11918564 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

0

Edits on 2 Mar, 2024

"update inverses"

edited on 2 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11912668 GCN2 and perk kinase inhibitors and methods of use thereof

0

"update inverses"

edited on 2 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11911370 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

0

Edits on 22 Feb, 2024

"update inverses"

edited on 22 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11903933 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

0

Edits on 27 Dec, 2023

"update inverses"

edited on 27 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11850241 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

0

"update inverses"

edited on 27 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11850240 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

0

Edits on 2 Dec, 2023

"Add patent abstract"

edited on 2 Dec, 2023

Edits made to:

Article (+196 characters)

Article

Patent abstract

The present invention provides a pyrido[2,3-d]pyrimidine compound, or a pharmaceutically acceptable salt thereof, that inhibits Raf and, therefore, may be useful in treating cancer.

Edits on 2 Nov, 2023

"update inverses"

edited on 2 Nov, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11801237 Amorphous kinase inhibitor formulations and methods of use thereof

Find more entities like US Patent 8741911 Raf inhibitor compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.